Pronova BioPharma Norge AS v. Teva Pharmaceuticals USA, Inc.
Certiorari Denied
Petition for certiorari denied on October 6, 2014.
Issue
Whether the statutory bar for "public use" of an invention under 35 U.S.C. § 102(b) (2006) (pre-America Invents Act) (current version at 35 U.S.C. § 102(a)(1)(2012)) broadly bars a patent when an innovator company allows any public access to its invention even if the invention is not actually used in public for its intended purpose.
Apr 16, 2014Petition for a writ of certiorari filed. (Response due May 19, 2014)
May 15, 2014Order extending time to file response to petition to and including June 18, 2014, for all respondents.
Jun 18, 2014Brief of respondent Teva Pharmaceuticals USA, Inc., et al. in opposition filed.Jul 2, 2014DISTRIBUTED for Conference of September 29, 2014.
Oct 6, 2014Petition DENIED.
Recommended Citation: Pronova BioPharma Norge AS v. Teva Pharmaceuticals USA, Inc., SCOTUSblog, https://www.scotusblog.com/cases/pronova-biopharma-norge-as-v-teva-pharmaceuticals-usa-inc/